p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes

Por Prodosmo, Andrea, De Amicis, Andrea, Nisticò, Cecilia, Gabriele, Mario, Di Rocco, Giuliana, Monteonofrio, Laura, Piane, Maria, Cundari, Enrico, Chessa, Luciana, Soddu, Silvia
Publicado em 2013

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination wit...

Por Fabi Alessandra, Russillo Michelangelo, Ferretti Gianluigi, Metro Giulio, Nisticò Cecilia, Papaldo Paola, De Vita Ferdinando, D’Auria Giuliana, Vidiri Antonello, Giannarelli Diana, Cognetti Francesco
Publicado em 2012-10-01

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination wit...

Por Fabi, Alessandra, Russillo, Michelangelo, Ferretti, Gianluigi, Metro, Giulio, Nisticò, Cecilia, Papaldo, Paola, De Vita, Ferdinando, D’Auria, Giuliana, Vidiri, Antonello, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2012

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients

Por Fabi, Alessandra, Giannarelli, Diana, Malaguti, Paola, Ferretti, Gianluigi, Vari, Sabrina, Papaldo, Paola, Nisticò, Cecilia, Caterino, Mauro, De Vita, Roy, Mottolese, Marcella, Iacorossi, Laura, Cognetti, Francesco
Publicado no Drug Des Devel Ther (2015)

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

Por Novelli, Flavia, Milella, Michele, Melucci, Elisa, Di Benedetto, Anna, Sperduti, Isabella, Perrone-Donnorso, Raffaele, Perracchio, Letizia, Venturo, Irene, Nisticò, Cecilia, Fabi, Alessandra, Buglioni, Simonetta, Natali, Pier Giorgio, Mottolese, Marcella
Publicado em 2008

Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials

Por Cuppone, Federica, Bria, Emilio, Giannarelli, Diana, Vaccaro, Vanja, Milella, Michele, Nisticò, Cecilia, Ruggeri, Enzo Maria, Sperduti, Isabella, Bracarda, Sergio, Pinnarò, Paola, Lanzetta, Gaetano, Muti, Paola, Cognetti, Francesco, Carlini, Paolo
Publicado em 2010

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Por Russillo Michelangelo, Nisticò Cecilia, Milella Michele, Carlini Paolo, Sperduti Isabella, Fabi Alessandra, Puglisi Fabio, Vaccaro Vanja, Bria Emilio, Cuppone Federica, Papaldo Paola, Ferretti Gianluigi, Aapro Matti, Giannarelli Diana, Cognetti Francesco
Publicado em 2011-05-01

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Por Cuppone, Federica, Bria, Emilio, Vaccaro, Vanja, Puglisi, Fabio, Fabi, Alessandra, Sperduti, Isabella, Carlini, Paolo, Milella, Michele, Nisticò, Cecilia, Russillo, Michelangelo, Papaldo, Paola, Ferretti, Gianluigi, Aapro, Matti, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2011

Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas

Por Folgiero, Valentina, Avetrani, Paolo, Bon, Giulia, Di Carlo, Selene E., Fabi, Alessandra, Nisticò, Cecilia, Vici, Patrizia, Melucci, Elisa, Buglioni, Simonetta, Perracchio, Letizia, Sperduti, Isabella, Rosanò, Laura, Sacchi, Ada, Mottolese, Marcella, Falcioni, Rita
Publicado em 2008